Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT04765072
  4. Details
NCT04765072 Clinical Trial

Expanding Rural Health Cancer Control Capacity

Cancer Clinical Trial

Official title:
Expanding Rural Health Cancer Control Capacity: Focus on Cancer Survivorship

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT04765072
Other study ID # VICC PED 2019
Secondary ID 3P30CA068485-24S
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 26, 2021
Est. completion date February 2029

Study information
Verified date July 2023
Source Vanderbilt-Ingram Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.

Description:

Study Aims: - Pilot test the implementation of guideline-based survivorship care planning in a rural setting using patient navigation plus telehealth among underserved rural cancer survivors. Investigators will collect feasibility data on patient recruitment rates and the ability to measure clinical effectiveness outcomes using the electronic health record and patient reports (survivor adherence to recommended disease surveillance, health assessment and cancer prevention/early detection practices). - Identify the facilitators and barriers to future larger scale implementation of guideline-based survivorship care planning in rural settings to optimize the implementation strategies. Through a mixed methods approach, investigators will address implementation research questions focused on "real world" implementation of the guideline-based intervention in rural areas, including barriers/facilitators and translation to other rural settings. This will allow us to optimize the implementation strategies that will be further evaluated in the future large-scale implementation trial

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 33
Est. completion date February 2029
Est. primary completion date February 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Cancer patient at least 18 years of age at time of cancer therapy - English-speaking with the ability to provide informed consent - Received treatment for Stage 0 - III cancer with curative intent - Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Survivorship Patient Navigation Intervention
Patient navigator assistance for navigating the healthcare system and locating and utilizing beneficial resources
• Telehealth Survivorship Visit Intervention
Individualized survivorship care plan

Locations
Country Name City State
United States Baptist Cancer Center- Bartlett Bartlett Tennessee
United States Baptist Cancer Center- Golden Triangle Columbus Columbus Mississippi
United States Vanderbilt-Ingram Cancer Center Nashville Tennessee
United States Baptist Cancer Center - North Mississippi Oxford Mississippi

Sponsors (2)
Lead Sponsor Collaborator
Debra Friedman National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of improvement in adherence to survivorship plan (Survivorship Care Planning Experience Satisfaction Survey (1-5 Excellent - Poor) Approximately 12 months
Primary Measure effectiveness of Telehealth on survivorship care Approximately 12 months
Primary Estimate the facilitators to a future larger-scale implementation of guideline-based survivorship care planning in rural settings Approximately 1 year
Primary Estimate the barriers to a future larger-scale implementation of guideline-based survivorship care planning in rural settings Approximately 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients